Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Urine-Based Immunoassays Developed for Visceral Leishmaniasis

By LabMedica International staff writers
Posted on 04 Nov 2016
Visceral Leishmaniasis (VL), a severe parasitic disease, and can be fatal if diagnosis and treatment is delayed and diagnostic tests available for VL such as tissue aspiration are invasive and painful although they are capable of evaluating the treatment response.

Post kala-azar dermal leishmaniasis (PKDL), a skin related outcome, is a potential reservoir for the spread of VL and parasitological examination of slit-skin smear along with the clinical symptoms is routinely used for diagnosis of PKDL. More...
Therefore, a noninvasive test with acceptable sensitivity and competency, additionally, to decide cure would be an asset in disease management and control.

Infectious disease specialists at the Indian Institute of Chemical Biology (Kolkata, India) enrolled 186 participants during March 2011 to July 2016. Urine samples of 97 parasitologically proven and rK39-RDT tested VL cases were obtained before the treatment started. Out of 97 VL samples, 18 were acquired for longitudinal study at different time points. Samples were also collected from 75 control subjects and 14 urine samples, which were confirmed by skin biopsy or slit-skin smear were collected from PKDL patients.

The team also performed enzyme-linked immunosorbent assays (ELISA) and the optical densities were read at 492 nm. The scientists also carried out dot blot assays and a nitrocellulose membrane-based dipstick was prepared to have a test and a control line for visual detection of the disease. Like dot blot assay the dipstick test comprises incubation with urine sample followed by enzyme-conjugated anti-human immunoglobulin G (IgG) and then substrate chromogen including washing in each step. Dark brown colored bands both at the test and control line show VL positivity and a single band at the control line infers VL negativity.

The team found that the ELISA and dipstick test were extremely effective for diagnosis of VL and PKDL through urine samples thus, may substitute the existing invasive diagnostics. Utility of these tests as indirect methods of monitoring parasite clearance can define infected versus cured. Urine-based dipstick test is simple, sensitive and above all noninvasive method that may help not only in active VL case detection but also to ascertain treatment response. It can therefore, be deployed widely for interventions in disease management of VL particularly in poor resource settings. The study was published on October 14, 2016, in the journal Public Library of Science Neglected tropical Diseases.

Related Links:
Indian Institute of Chemical Biology



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.